https://www.selleckchem.com/products/U0126.html
Intracavitary and/or interstitial brachytherapy is an integral component of the management of patients with central pelvic-recurrent cervical cancer after primary hysterectomy, and is typically delivered using conventional applicators. We investigated the efficacy and safety of three-dimensional (3D)-printed, customizable applicators for those patients. Twenty-six patients were treated with combination external beam radiotherapy and brachytherapy. Patients with lesions ≤1 and 1 cm before brachytherapy were treated with intracavitary a
Gefällt mir
Kommentar
Teilen
